Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelu Desai

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Current Pharmaceutical Design|January 27, 2025
Efficacy and Safety of Altibrain® as an Adjunctive Therapy for Autism Spectrum Disorder: An Open Label Trial Targeting Core SymptomsSidharth Mehan, Aakash Kumar, Prashant R Utage, et al.
Journal of Neuromuscular Diseases|October 23, 2025
Spinal muscular atrophy in India: Patient journey, access to care, treatment barriers, and strategic recommendations: Insights from expertsSheffali Gulati, Anzeen Nazir Kanth, Ashwin Dalal, et al.
Pediatric Neurology|September 18, 2025
Validation and Modified Application of the 2023 International Expert Consensus Criteria for Diagnosing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Among Children With Acquired Demyelination in Resource-Limited RegionsVishal Sondhi, Neelu Desai, Lokesh Lingappa, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Current Pharmaceutical Design|January 27, 2025
Efficacy and Safety of Altibrain® as an Adjunctive Therapy for Autism Spectrum Disorder: An Open Label Trial Targeting Core SymptomsSidharth Mehan, Aakash Kumar, Prashant R Utage, et al.
Journal of Neuromuscular Diseases|October 23, 2025
Spinal muscular atrophy in India: Patient journey, access to care, treatment barriers, and strategic recommendations: Insights from expertsSheffali Gulati, Anzeen Nazir Kanth, Ashwin Dalal, et al.
Pediatric Neurology|September 18, 2025
Validation and Modified Application of the 2023 International Expert Consensus Criteria for Diagnosing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Among Children With Acquired Demyelination in Resource-Limited RegionsVishal Sondhi, Neelu Desai, Lokesh Lingappa, et al.
Pageof 2